Transaction · 0001415889-25-006684

Winningham Rick E

Winningham Rick E, CEO, reported a transaction classified as grant at Theravance Biopharma, Inc. involving 2178.000000 shares for an estimated $20364.30. Reported holdings after the transaction were 1778144.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACEO
TBPHTheravance Biopharma, Inc.
Filing timeMar 04
Trade dateFeb 28, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

TBPH price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
TBPH since 2025-03-04Filed 548 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0001415889-25-006684
Ordinary Shares
Transaction date
Feb 28, 2025
Filed Mar 04, 2025, 11:17 PM · 4d delay
Shares
2.17k sh
$935 per share
Estimated value
$2.03M
Computed from shares × price
Holdings after
1.77M sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
-16score
Filing-only score

-16

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CHIEF EXECUTIVE OFFICER

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Reflects an acquisition from the Issuer pursuant to a restricted share purchase agreement under the Issuer's Amended and Restated 2013 Equity Incentive Plan at a per-share price equal to the closing p…

Original filing · 0001415889-25-006684
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

TBPH